Thomas Flaten
Stock Analyst at Lake Street
(3.21)
# 1,094
Out of 5,150 analysts
36
Total ratings
42.11%
Success rate
5.84%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $8 → $12 | $5.47 | +119.38% | 1 | Feb 17, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $28.17 | +84.59% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $23.01 | +117.30% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.59 | +247.49% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.42 | +163.16% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $3.11 | +253.70% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $39.22 | +78.48% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $8.04 | +61.69% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.36 | +83.49% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.77 | +80.18% | 2 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.61 | +207.10% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $15.30 | +161.44% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.37 | +83.07% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.93 | +0.78% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $12.07 | +272.83% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.58 | +140.17% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $20.67 | +20.95% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.50 | +285,104.99% | 2 | Nov 17, 2022 |
Insight Molecular Diagnostics
Feb 17, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $5.47
Upside: +119.38%
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $28.17
Upside: +84.59%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $23.01
Upside: +117.30%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.59
Upside: +247.49%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.42
Upside: +163.16%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $3.11
Upside: +253.70%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $39.22
Upside: +78.48%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $8.04
Upside: +61.69%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.36
Upside: +83.49%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.77
Upside: +80.18%
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.61
Upside: +207.10%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $15.30
Upside: +161.44%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $4.37
Upside: +83.07%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $8.93
Upside: +0.78%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $12.07
Upside: +272.83%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.58
Upside: +140.17%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $20.67
Upside: +20.95%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.50
Upside: +285,104.99%